One of the eye care profession’s most in-demand speakers will headline the Vision Expo West 2023 Global Contact Lens Forum, which is scheduled for Wednesday, September 27 in Las Vegas. For the first time, Centre for Ocular Research & Education (CORE) Director Lyndon Jones joins the event’s faculty, sharing insights alongside peers Melissa Barnett, Jason Compton, Janelle Davison, and Sheila Morrison.

The Forum ‘meeting within a meeting’ design—which runs from 8:30 am to 3:15 pm PT—is structured to provide practical, timely clinical and business processes tips for any professional that recommends, fits, or prescribes contact lenses. Topics include new products and technologies, ‘leveling up’ practice management pearls, and the good, bad, and ugly of myopia control. Participants can earn up to four hours of continuing education (CE) credits at no additional cost.

Dr. Jones will also join Dr. Barnett, Dr. Compton, and Dr. Shalu Pal the following day for “The Greatest Contact Lens Course Ever.” The two-hour session promises a series of rapid-paced presentations, including drug delivery, myopia management and scleral lenses, to expand attendees’ contact lens knowledge and patient interactions.

Vision Expo West pre-registration for educational courses is required at

Dr. Jones has delivered more than 1,000 invited lectures at conferences in more than 40 countries, has authored over 400 refereed and professional papers, and is rated among the top 10 optometry researchers worldwide by He most recently was a featured speaker at the 4th World Congress of Optometry / O=MEGA23 conference in Melbourne, Australia.

# # #

About the Centre for Ocular Research & Education (CORE)
The Centre for Ocular Research & Education (CORE) was established in 1988 at the University of Waterloo’s School of Optometry & Vision Science. Over the next three decades, the organization evolved from a three-person operation into a thriving hub of basic and applied research, collaborating with sponsors, agencies and academia on advanced biosciences, clinical research and education. Its uncompromising independence and results of the highest quality have been at the heart of many of the most prominent advances in eye health. Today, its approximately 50-person team serves a range of ophthalmic sectors, including medical devices, ocular pharmaceuticals, digital technology and others, with a focus on the anterior segment. For more information, please visit